Sodium Hyaluronate Analysis
Sodium hyaluronate (NaHA) is a critical ingredient in pharmaceutical formulations, medical devices and life science applications. At RSSL, we offer a comprehensive suite of testing services aligned with European Pharmacopeia (Ph. Eur) standards to help you verify the identity, purity and concentration of NaHA, supporting your product’s regulatory success and market readiness.
What is Sodium Hyaluronate? Sodium hyaluronate is the sodium salt of hyaluronic acid which is widely used for its hydrating and viscoelastic properties. It is widely used in treatments for joint disorders, ophthalmic solutions, skin care formulations and medical device applications. Given its functional versatility, tight regulatory benchmarks relating to quality attributes including concentration, impurity profile and microbiological purity is essential to ensure safety and efficacy.
Our expert scientists perform an extensive range of Ph. Eur compliant tests designed to meet the exact requirements of your formulations
RSSL is a trusted partner to leading global manufacturers, supporting regulatory compliance and product excellence through a uniquely comprehensive approach. Our deep understanding of Pharmacopeia monographs and international regulatory requirements ensures that clients remain aligned with global standards. This expertise is backed by state of the art facilities and advanced analytical technologies, enabling us to tackle even the most complex testing challenges.
We are committed to exceptional customer service, offering responsive communication, fast turnaround times, and tailored testing solutions that meet the specific needs of each client. With decades of experience and a proven track record, RSSL consistently delivers reliable, high-quality data to the Life Science industry.
Whether you’re developing a new sodium hyaluronate based product or validating a current formulation, RSSL provides the analytical support and regulatory assurance you need to move forward with confidence.
